FCX vs PROF · P/E 38, rev $25.45B vs rev $10.7M
Freeport-McMoran Copper & Gold Inc (FCX) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported FCX revenue for 2024-12-31 was $25.45B. Net income was $4.40B. Revenue was up 11.4% from 2023-12-31 to 2024-12-31. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. PROF currently screens at market cap $238.7M.
Not investment advice. Open the FCX and PROF stock pages for the full models.
Not investment advice.